Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-1973 in Patients With Stable Type 2 Diabetes and Hypertension
NCT03091920Phase 2Completed
- Sponsor
- Cyclerion Therapeutics
- Start
- Feb 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of praliciguat in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by Cyclerion Therapeutics. Started Feb 2017; status: completed.
02
Drugs
praliciguat
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT03091920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091920.